Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 27, 2012
[A case of pancreaticoduodenectomy for duodenal carcinoma with a replaced common hepatic artery running through the pancreatic parenchyma]Isamu Hosokawa, Hiroaki Shimizu, Masayuki Nakajima, et al.
Pancreas|March 23, 2006
Increased plasma levels of IL-6 and IL-8 are associated with surgical site infection after pancreaticoduodenectomyFumio Kimura, Hiroaki Shimizu, Hiroyuki Yoshidome, et al.
The American Journal of Surgical Pathology|March 18, 2011
Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretionMasayuki Ohtsuka, Fumio Kimura, Hiroaki Shimizu, et al.
The Journal of Surgical Research|January 3, 2006
Circulating cytokines, chemokines, and stress hormones are increased in patients with organ dysfunction following liver resectionFumio Kimura, Hiroaki Shimizu, Hiroyuki Yoshidome, et al.
Journal of Hepato-Biliary-Pancreatic Surgery|July 27, 2007
Aggressive surgical approach for stage IV gallbladder carcinoma based on Japanese Society of Biliary Surgery classificationHiroaki Shimizu, Fumio Kimura, Hiroyuki Yoshidome, et al.
Hepato-Gastroenterology|May 21, 2009
Surgical management of occluded biliary expandable metallic stent for benign stricture of bilioenteric anastomosis: usefulness of anterior transhepatic procedureHiroaki Shimizu, Fumio Kimura, Hiroyuki Yoshidome, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 30, 2013
Protective effects of simultaneous splenectomy on small-for-size liver graft injury in rat liver transplantationTakuya Yoichi, Tsukasa Takayashiki, Hiroaki Shimizu, et al.
Cancer Chemotherapy and Pharmacology|August 7, 2009
Expression of an activated mammalian target of rapamycin (mTOR) in gastroenteropancreatic neuroendocrine tumorsTakashi Shida, Takashi Kishimoto, Mitsuko Furuya, et al.
The Journal of Surgical Research|June 26, 2012
Akt/mTOR signaling pathway is crucial for gemcitabine resistance induced by Annexin II in pancreatic cancer cellsShingo Kagawa, Shigetsugu Takano, Hideyuki Yoshitomi, et al.
Surgery Today|August 30, 2008
Clinical implications of unusual NeuroD and mASH1 expression in a patient with primary large-cell neuroendocrine carcinoma of the duodenum: report of a caseSeiki Miura, Hiroyuki Yoshidome, Takashi Shida, et al.
Pageof 12